From ideals to execution – exploring the realities of patient-centricity
The Ashfield Patients & Pharma Future Forum explores the reality of patient-centricity in 2016 and what’s next for pharma.
Since
eyeforpharma, Barcelona 2015, we have heard industry,
vendors,
specialists, advocacy groups and patients talking about patient-centricity:
what is it? What does it mean for the industry
and the wider
healthcare environment? What does it mean for
patients? What
will it look like in the future?
However, one
question that’s been missing recently is “Why does it matter?” The reason this question
is no longer
prominent is that we have moved past the phase where we are looking for a rationale to
drive
towards a more patient-centric industry, and we are now actually trying to shape, deliver and measure
it.
We wanted
to understand how the industry was moving from vision to reality
in patient-centricity. What we wanted to understand was the reality of patient-centricity today, the truth
behind the buzzwords and challenges
in
delivering this vision. Whobetter to ask than industryrepresentatives?
We convened
a panel of 12 representatives from pharmaceutical companies, including large broad
portfolio
companies as well as smaller/mid-sized more specialist providers, in a mix of patient-centred
roles from
Chief Patient Officer through to regional and
functional patient leads. We ran a 2-week online expert panel earlier this year,
inviting our
panel to discuss, as openly as possible, their company vision, the strategy and structure
that they
were putting in place for delivering the vision, and the
key challenges they had found in moving towards patient-centricity. The panel
was
moderated by Andrew Schorr of Patient Power, along with
Ashfield Healthcare Communications.
Click here to download our “From ideals to
execution” whitepaper to learn more about the insights shared during our
Patients & Pharma Future Forum and what’s next for pharma.
Project Manager uses personal development funding to support friends' and colleagues' well-being – by Helen Capelin Head of Operational Excellence. Ashfield
We are happy to announce that we have officially moved into our Manchester office! This will be our 16th office for Ashfield Healthcare Communications along with our others across Europe, America, and Asia-Pacific. Ashfield
Client Relationship Director Fabienne Wild from Ashfield Meetings & Events reflects on the recent conference season and on her experience at the European Society for Medical Oncology (ESMO). Ashfield
Today's healthcare companies are looking for an agile and responsive partner to help them overcome complex challenges, deliver innovative products and break into new markets. Ashfield
Ashfield Healthcare Communications, a leading global healthcare communications agency, today welcomes its third intake of aspiring medical writers into its accelerated medical writing training programme, Allegro. Ashfield